SynCardia Facebook SynCardia Twitter SynCardia LInkedIn SynCardia Google Plus SynCardia Youtube

SynCardia Systems, Inc.

Press Release:

SynCardia Co-Founder to Give Keynote Speech at Pumps & Pipes 2010

Dr. Marvin Slepian to Present on Total Artificial Heart at Collaborative Initiative Between Energy and Medicine in Houston

Marvin J. Slepian, Professor of Medicine (Cardiology and Biomedical Engineering) at the University of Arizona, co-founder and chairman of SynCardia Systems, Inc Marvin J. Slepian, Professor of Medicine (Cardiology and Biomedical Engineering) at the University of Arizona, co-founder and chairman of SynCardia Systems, Inc TUCSON, Ariz. – Dec. 2, 2010 – On Dec. 6, Marvin J. Slepian, M.D., Professor of Medicine (Cardiology and Biomedical Engineering) at the University of Arizona and co-founder and chairman of SynCardia Systems, Inc., manufacturer of the SynCardia temporary Total Artificial Heart, will be one of three keynote speakers at "Pumps & Pipes 4: No Boundaries," held at the Methodist Hospital Research Institute in Houston. The goal of Pumps & Pipes is to foster and build unique research opportunities between energy and medicine – Houston's largest industries - to enhance and develop resources and technologies.

According to the Pumps & Pipes website, "Much like moving oil through a pipeline, the heart must pump blood through vessels. Our intention is to stimulate discussion, spark ideas, explore synergies between these industries that face similar challenges in imaging, navigation, metallurgy, fluid dynamics, robotics and remote monitoring."

"The Total Artificial Heart is an example of several unique engineering marvels," said Dr. Slepian. "It has the shortest blood flow path (<20cm), which reduces the risk of thromboembolitic events, and the widest inflow and outflow diameters, which allows for high cardiac output (up to 9.5 L/min) while maintaining normal central venous pressure, which is essential for patient recovery." 

In addition to discussing the development and clinical use of the world's only FDA, Health Canada and CE approved Total Artificial Heart, Dr. Slepian will also discuss the new 13.5 lb Freedom driver, the first U.S. portable driver designed to power the Total Artificial Heart both inside and outside the hospital. The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.

Dr. Slepian is Director of Interventional Cardiology and Director of the Tissue Engineering Lab at the University of Arizona. He has founded numerous medical device companies and has served as acting CEO and Board Member of several medical device startups. Additionally, Dr. Slepian has conducted extensive research, development and pre-clinical investigation of novel cardiovascular therapeutic methods and devices.


###

About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the temporary Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.

Follow SynCardia: Facebook | Twitter | LinkedIn | Google+

SynCardia Contact:
Janelle Drumwright, jdrumwright@syncardia.com, (520) 547-7463

Search offcanvas